Literature DB >> 3667142

Clinical and therapeutic studies in mesangial immunoglobulin A glomerulonephritis.

N Belovezhdov1, R Robeva.   

Abstract

A long-term clinical and therapeutic study was performed in 47 patients with mesangial IgA glomerulonephritis. The male to female ration was 2.9:1. An episode of gross haematuria or the incidental discovery of asymptomatic microscopic haematuria with associated mild proteinuria heralded the apparent onset of renal disease. At the onset of observation 18 patients (38.2%) had high blood pressure. Other 17 patients developed hypertension during observation. Anaemia was uncommon. No essential abnormalities in serum protein and lipid patterns were found. Twenty-nine patients (61.6%) had higher levels of serum immunoglobulins--most frequently of IgA (42.5%). Twenty-two patients had low serum C3 levels (46.8%). The percentage of patients with renal failure increased from 21.2 to 36.1 during observation. Male sex, hypertension, proteinuria higher than 2 g/24 h, elevated ESR, high serum IgA levels, longer duration of the disease and older age of patients suggest an unfavourable outcome. Long-term treatment with a combination of azathioprine/acenocumarol, or indomethacin, or levamisole has no effect on the clinical manifestation and evolution.

Entities:  

Mesh:

Year:  1987        PMID: 3667142     DOI: 10.1007/bf02549873

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  15 in total

1.  [Glomerulonephritis with diffuse IgA deposits in the mesangium. Study of 96 adult cases].

Authors:  P de Werra; L Morel-Maroger; C Leroux-Robert; G Richet
Journal:  Schweiz Med Wochenschr       Date:  1973-05-26

2.  IgA glomerular deposits in renal disease.

Authors:  J Berger
Journal:  Transplant Proc       Date:  1969-12       Impact factor: 1.066

3.  [Primary glomerulopathy with IgA and IgG mesangial deposits. Clinical and morphological study of 52 cases].

Authors:  P Druet; J Bariety; D Bernard; G Lagrue
Journal:  Presse Med       Date:  1970-03-14       Impact factor: 1.228

4.  IgA glomerulonephritis, asymptomatic hematuria, and systemic disease.

Authors:  D C Batlle
Journal:  Arch Intern Med       Date:  1981-09

5.  Is there a treatment of mesangial IgA glomerulonephritis?

Authors:  G Lagrue; T Sadreux; J Laurent; G Hirbec
Journal:  Clin Nephrol       Date:  1981-09       Impact factor: 0.975

6.  Phenytoin in IgA nephropathy: a long-term controlled trial.

Authors:  J Egido; F Rivera; J Sancho; A Barat; L Hernando
Journal:  Nephron       Date:  1984       Impact factor: 2.847

7.  IgA glomerulonephritis. Mesangial IgA deposition without systemic signs (Berger's disease).

Authors:  J Nagy; H Brasch; T Süle; A Hámori; G Deák; M Ambrus
Journal:  Int Urol Nephrol       Date:  1979       Impact factor: 2.370

8.  Intrarenal vascular sclerosis in IgA nephropathy.

Authors:  H D Feiner; S Cabili; D S Baldwin; R G Schacht; G R Gallo
Journal:  Clin Nephrol       Date:  1982-10       Impact factor: 0.975

9.  Mesangial IgA glomerulonephritis. Clinicopathological study of 85 cases.

Authors:  H Yokoska; M Nagase; T Maeda; K Koide
Journal:  Contrib Nephrol       Date:  1978       Impact factor: 1.580

10.  IgA-IgG nephropathy: predictive indices of progressive disease.

Authors:  S A Hood; J A Velosa; K E Holley; J V Donadio
Journal:  Clin Nephrol       Date:  1981-08       Impact factor: 0.975

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.